MRUS Valuation

Merus NV

Add to Watchlist

Advanced Chart

96.050

-0.03(-0.031%)1D

MRUS Relative Valuation

MRUS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MRUS is overvalued; if below, it's undervalued.

Historical Valuation

Merus NV (MRUS) is now in the Overvalued zone, suggesting that its current forward PS ratio of 96.08 is considered Overvalued compared with the five-year average of -10.49. The fair price of Merus NV (MRUS) is between 25.44 to 81.93 according to relative valuation methord. Compared to the current price of 96.13 USD , Merus NV is Overvalued By 17.33%.

Relative Value

Fair Zone

25.44-81.93

Current Price：96.13

17.33%

Overvalued

-19.87

Trailing

Forward

-17.67

EV/EBITDA

Merus NV. (MRUS) has a current EV/EBITDA of -17.67. The 5-year average EV/EBITDA is -6.61. The thresholds are as follows: Strongly Undervalued below -13.19, Undervalued between -13.19 and -9.90, Fairly Valued between -3.31 and -9.90, Overvalued between -3.31 and -0.02, and Strongly Overvalued above -0.02. The current Forward EV/EBITDA of -17.67 falls within the Strongly Undervalued range.

-16.02

EV/EBIT

Merus NV. (MRUS) has a current EV/EBIT of -16.02. The 5-year average EV/EBIT is -6.71. The thresholds are as follows: Strongly Undervalued below -12.77, Undervalued between -12.77 and -9.74, Fairly Valued between -3.68 and -9.74, Overvalued between -3.68 and -0.65, and Strongly Overvalued above -0.65. The current Forward EV/EBIT of -16.02 falls within the Strongly Undervalued range.

96.08

Merus NV. (MRUS) has a current PS of 96.08. The 5-year average PS is 46.16. The thresholds are as follows: Strongly Undervalued below -24.43, Undervalued between -24.43 and 10.86, Fairly Valued between 81.45 and 10.86, Overvalued between 81.45 and 116.74, and Strongly Overvalued above 116.74. The current Forward PS of 96.08 falls within the Overvalued range.

-24.85

P/OCF

Merus NV. (MRUS) has a current P/OCF of -24.85. The 5-year average P/OCF is -11.99. The thresholds are as follows: Strongly Undervalued below -22.32, Undervalued between -22.32 and -17.16, Fairly Valued between -6.83 and -17.16, Overvalued between -6.83 and -1.67, and Strongly Overvalued above -1.67. The current Forward P/OCF of -24.85 falls within the Strongly Undervalued range.

-20.17

P/FCF

Merus NV. (MRUS) has a current P/FCF of -20.17. The 5-year average P/FCF is -10.17. The thresholds are as follows: Strongly Undervalued below -17.96, Undervalued between -17.96 and -14.06, Fairly Valued between -6.27 and -14.06, Overvalued between -6.27 and -2.38, and Strongly Overvalued above -2.38. The current Forward P/FCF of -20.17 falls within the Strongly Undervalued range.

Merus NV (MRUS) has a current Price-to-Book (P/B) ratio of 9.40. Compared to its 3-year average P/B ratio of 5.10 , the current P/B ratio is approximately 84.51% higher. Relative to its 5-year average P/B ratio of 4.76, the current P/B ratio is about 97.36% higher. Merus NV (MRUS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -9.23%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -9.19% , the current FCF yield is about -100.00% lower.

9.40

P/B

Median3y

5.10

Median5y

4.76

-4.36

FCF Yield

Median3y

-9.23

Median5y

-9.19

Competitors Valuation Multiple

The average P/S ratio for MRUS's competitors is 72.74, providing a benchmark for relative valuation. Merus NV Corp (MRUS) exhibits a P/S ratio of 96.08, which is 32.08% above the industry average. Given its robust revenue growth of 3.21%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Caris Life Sciences Inc

24.30

6.86B

AXSM.O

Axsome Therapeutics Inc

Halozyme Therapeutics Inc

Performance Decomposition

Market capitalization of MRUS increased by 114.27% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -8.20 to -17.92.

The secondary factor is the Revenue Growth, contributed 3.21%to the performance.

Overall, the performance of MRUS in the past 1 year is driven by P/E Change. Which is more unsustainable.

3.21%

11.77M → 12.15M

Revenue Growth

-7.36%

-848.67 → -786.17

Margin Expansion

118.42%

-8.20 → -17.92

P/E Change

114.27%